Log In
Print this Print this

C. difficile vaccine (VLA84) (formerly IC84)

Also known as: IC48

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionRecombinant protein vaccine consisting of 2 truncated toxins A and B from Clostridium difficile
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationClostridium
Indication DetailsVaccinate against C. difficile infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today